HOME >> BIOLOGY >> NEWS
Antibody therapy prevents type 1 diabetes in mice

PITTSBURGH, Jan. 8 University of Pittsburgh investigators have successfully prevented the onset of type 1 diabetes in mice prone to developing the disease using an antibody against a receptor on the surface of immune T-cells. According to the investigators, these findings, which are being published in the January issue of the journal Diabetes, have significant implications for the prevention of type 1 diabetes.

More than 700,000 Americans have type 1 diabetes, an autoimmune disorder in which the body errantly attacks the insulin-producing cells of the pancreas, causing chronically elevated levels of sugar in the blood, leading to blindness, kidney failure, heart disease and nerve damage. Previously known as juvenile diabetes, type 1 diabetes is usually diagnosed at a very early age, but in some cases it can be diagnosed in adulthood.

In this study, the Pitt researchers treated non-obese diabetic (NOD) mice with an antibody -- a type of protein produced by the immune system that recognizes and helps fight infections and other foreign substances in the body -- directed against a receptor known as CD137 on the surface of a type of immune cell called T-cells. Treating NOD mice with the anti-CD137 antibodies significantly suppressed the development of diabetes, whereas most of the control mice developed diabetes by the time they were six months old.

Interestingly, the antibody therapy did not appear to cure the NOD mice because the researchers were still able to see lymphocytes in their pancreatic islets, a tell-tale sign of pancreatic inflammation and autoimmunity. In addition, when the researchers isolated cells from the spleens of the antibody-treated mice and injected these cells into immune-deficient NOD mice, seven of the nine recipient mice developed type 1 diabetes, indicating that the donor mice still harbored pathogenic T-cells. On the other hand, when the researchers transferred a certain subset of T-cells from anti-CD137-trea
'"/>

Contact: Jim Swyers
swyersjp@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
8-Jan-2007


Page: 1 2

Related biology news :

1. Antibody-altering protein found in developing B cells
2. Antibody retards growth and induces death in liver cancer cells
3. Antibody linked to MS significantly higher in spinal fluid of blacks
4. Antibody-based therapies effective at controlling malaria
5. Antibody extends life of mice with breast cancer
6. Antibody to a naturally-occurring sugar chain in colon inhibits inflammatory bowel disease
7. Antibody that neutralizes most HIV strains described by scientists at The Scripps Research Institute
8. Testosterone replacement therapy: How safe for aging men?
9. Progesterone therapy and preterm birth: More evidence helps identify women who can benefit
10. Aggressive therapy best for certain AML patients
11. Under magnetic force, nanoparticles may deliver gene therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... SAN MATEO, Calif. (PRWEB) , ... September 03, 2020 , ... ... that the Brilliant Smart Home System and its products are now available for purchase ... wholesale distributor of smart home, security, AV, and low-voltage products. In addition to being ...
(Date:9/3/2020)... , ... September 03, 2020 , ... ... data, today announced that an extensive third-party assessment of the company’s security practices ... when measured against federal security regulations. The comprehensive evaluation reviewed Litmus’ processes and ...
(Date:8/26/2020)... , ... August 24, 2020 , ... ... the treatment of chronic inflammatory and fibrotic diseases, today announced that Dr. Stacie ... of Drug Discovery. , Dr. Canan previously served as Executive Director of Global ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone Partners ... has announced the placement of Julianne Averill , CPA, as Chief Financial ... financial operations and implementing key business strategies to accelerate Alveo’s growth as the ...
(Date:8/12/2020)... ... 11, 2020 , ... The FSHD Society announced today that ... Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on funding of ... academic research centers in the United States and Europe with expertise in FSHD ...
(Date:8/3/2020)... ... , ... ERT, the global leader in clinical ... one of the 100 most inspiring individuals in the life-sciences industry by PharmaVoice. ... on how they have inspired their colleagues and affected positive changes in their ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: